Ignite Creation Date:
2025-12-24 @ 6:42 PM
Ignite Modification Date:
2025-12-26 @ 5:38 PM
Study NCT ID:
NCT05849857
Status:
RECRUITING
Last Update Posted:
2023-11-01
First Post:
2023-03-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Mosunetuzumab for Early Relapse of Follicular Lymphoma in the Nordic Countries
Sponsor:
Oslo University Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-09-11
Start Date Type:
ACTUAL
Primary Completion Date:
2027-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-08
Completion Date Type:
ESTIMATED
First Submit Date:
2023-03-22
First Submit QC Date:
None
Study First Post Date:
2023-05-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-31
Last Update Post Date:
2023-11-01
Last Update Post Date Type:
ACTUAL